Join us.

Drug Discovery

Translational Medicine Scientist

With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.


The Role

We are seeking a Clinical/Molecular Epidemiologist with a passion for applying their skills in the analysis of public health data, clinical trial and electronic health records in the context of Drug Discovery. You will join a diverse team of Translational Medicine Scientists and will use your skills in collaboration with genetic, genomic, and AI/ML scientists to define clinical phenotypes that will impact the drug discovery and clinical development programmes at BenevolentAI.

Primary Responsibilities

  • You will bring expertise in the analysis and interpretation of clinical phenotyping data to Benevolent’s precision medicine approaches.
  • You will work as a member of a cross-functional team comprising specialists in genomics, genetics, informatics, engineering, AI and drug discovery. In these teams, you will apply the latest advances in machine learning to drug discovery and development.
  • You will define the scientific and technical problems in delivering precision medicine to develop new solutions within your team, influence a precision medicine approach across the company and be part of collaborative teams with external partners.
  • You will drive an approach of ‘clinic first’ to define unmet medical needs in patient-level data and match targets that address that need to existing or new therapeutic agents.

We are looking for someone with

  • A PhD in epidemiology (clinical/molecular/genomic), biostatistics, statistical genetics or related fields of research.
  • At least one first-author publication or equivalent in the fields of epidemiology, drug discovery or bioinformatics.
  • Experience handling, analysing and interpreting large-scale clinical epidemiological data, real-world evidence (RWE) data, or clinical trial datasets.
  • Experience in at least one programming language e.g. Python (preferred) or R.
  • Experience working with standard data science tools.
  • Collaborative, team-oriented, able to thrive in a multidisciplinary environment.
Nice to haves...
  • 3 years or more experience of applying epidemiological approaches in conjunction with genetic and/or genomic data to further disease phenotype understanding ideally in the context of drug discovery or development, or translational science in a commercial or academic setting.
  • Experience in the analysis of UK Biobank data, healthcare RWE data or equivalent large scale human phenotype data.
  • Understanding of clinical development and trial design.
  • Familiarity with biomarker discovery and development.

We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey.  If that sounds like a fit for you, hit the apply button and join us.

About us

BenevolentAI (AMS: BAI) is a leading, clinical-stage AI-enabled drug discovery and development company listed on the Euronext Amsterdam stock exchange. Through the combined capabilities of its AI platform, scientific expertise, and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform™ powers a growing in-house pipeline of 13 named drug programmes and over 10 exploratory programmes, and it maintains successful collaborations with AstraZeneca, as well as leading research and charitable institutions. BenevolentAI is headquartered in London, with a research facility in Cambridge (UK) and a further office in New York.

Want to do a little more research before you apply?

Head over to our Glassdoor page to learn about our benefits, culture and to find out what our team thinks about life at Benevolent. You can also find out more about us on LinkedIn and Twitter.

Important Note

Our team will only contact you from the domain If you receive a suspicious contact request, please email Thank you.